Market cap
$1,783 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
212.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 550.00 | -15.98 | -36.72 |
| EBIT | -3.57 | -21.52 | 22.30 | 5.07 | -22.85 |
| Net Profit | -9.60 | -27.91 | 15.59 | 6.87 | -25.36 |
| EPS | -9.01 | -26.26 | 17.71 | -149.90 | -213.38 |
| Book Value | -- | -- | -94.41 | -27.27 | -23.74 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 276,382.75 | 164,458.74 | -- | -9,835.15 | 850,532.50 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 410.92 | 168.37 | -- | -197.85 | 1,905.92 |
| Return on Capital
| 217.23 | 101.65 | -- | -109.15 | 853.87 |
| Return on Assets
| 174.83 | 80.62 | -63.77 | -85.60 | 690.69 |
| Debt to Equity (x)
| -- | -- | -3.33 | 13.39 | 0.06 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
-109.15
|
853.87
|
-93.05
|
-74.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
-197.85
|
1,905.92
|
-475.31
|
-263.00
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-63.77
Lower than Peers by 32.53
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
-63.77
|
-85.60
|
690.69
|
-80.62
|
-65.81
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
-9,835.15
|
850,532.50
|
-11,549.11
|
-5,795.71
|
|
Peer Median
|
-82.60
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
-10,773.46
|
843,786.00
|
-13,408.94
|
-6,625.27
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
5.50
|
-0.89
|
-0.18
|
-0.70
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
22.30
Higher than Peers by 23.32
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
22.30
|
-107.52
|
918.28
|
-63.63
|
-65.93
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
15.59
Higher than Peers by 23.12
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
15.59
|
-108.30
|
799.19
|
-66.20
|
-77.61
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
17.71
Higher than Peers by 3.48
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
17.71
|
-1.08
|
27.10
|
-0.33
|
-0.58
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
-176.28
Lower than Peers by 166.15
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
-176.28
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-3.33
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
-3.33
|
13.39
|
0.06
|
4.83
|
3.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.05
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
-0.05
|
0.29
|
0.01
|
0.05
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
5.07
Lower than Peers by 0.74
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
5.07
|
3.93
|
3.94
|
5.25
|
10.17
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
5.07
Lower than Peers by 0.63
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
5.07
|
--
|
--
|
--
|
10.18
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-7.88
Lower than Peers by 5.79
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
-7.88
|
-10.48
|
126.09
|
-6.53
|
-7.89
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
13.62
|
210.00
|
43.22
|
11.72
|
|
Peer Median
|
19.01
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
0.01
|
0.00
|
0.01
|
0.01
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
83.87
|
1,093.92
|
105.01
|
94.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
--
|
--
|
-78.82
|
-1.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
1,117.15
|
1,614.37
|
2,956.35
|
28.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
--
|
--
|
-2,930.15
|
63.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
-8.74
|
0.13
|
-8.51
|
-7.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
212.28
Higher than Peers by 206.96
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
212.28
|
153.07
|
1.67
|
47.20
|
18.36
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.13
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
0.13
|
-9.62
|
0.05
|
-9.61
|
-7.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
1,783
Higher than Peers by 1,642
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Inhibrx Inc (INBX)
|
1,783
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|